Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by august202013on Apr 04, 2023 11:53am
218 Views
Post# 35378766

MAY BE CONCERTED EFFORT TO FLUSHED LONG-TERM HOLDERS

MAY BE CONCERTED EFFORT TO FLUSHED LONG-TERM HOLDERS SLOWLY BELIEVE SOME GROUP WITH THE KNOW INFORMATION (TAKE OVER BID OFFERS) ? WANT TO FLUSHED OUT ALL LONG-TERM MEDMIRA SHAREHOLDERS BEFORE TAKING MEDMIRA PRIVATE AND BEFORE SELLING IT TO "AB. O. T. "
JUST FOR MEDMIRA PATENTED RAPID VERTICAL FLOW TECHNOLOGY ALONE WHAT MORE PLUS ALL OTHER BONUSES VYRA/COVID19 TEST KIT PLUS +.

SEE THIS COMPANY'S DEBTS ARE MANAGEABLE NOT TOO MUCH UNDER CARPET. 

IDEA IS TO FRUSTRATE MINORITY MEDMIRA LONG-TERM SHAREHOLDER AS VERY UNIQUE SITUATION HERE AS THERE ARE MANY HARDCORE WHO REFUSE TO UNLOAD NO MATTER WHAT SO ONLY WAY IS TO WORK IN CONCERT WITH BIG BROTHER TO KIV ALL APPROVAL UNTIL SUCH TIME. PROBABLY EXPLAINS WHY WITHDRAWAL OF FIRST EUA THEN EUA FOR COVID19 TEST KIT PLUS DELAY TILL TODAY. ALSO REFUSED ASSISTANCE TO TAKE COVID19 TEST KIT PLUS INTO SOUTH EAST ASIA AS EARLY AS JANUARY 2021 STILL DURING COVID19 PEAK TIMES.

SEE REPEATEDLY PATTERN OF BIDS SELLER/BUYER. MANY TIME IF VOLUME ALOT PROBABLY SOMEONE GOT UPSET AND EXIT BUT MOST OF TIME IS SAME PERSON MARY TRANSACTION IE SAME BUYER AND SELLER.

PERHAPS REGULATORS SECURITIES COMMISSIONS SHOULD INVESTIGATE SUCH ACTS EVEN DOING THROUGH NOMINEES.

IF THE THEORY IS CORRECT END OF DAY THERE IS A MASSIVE LAWSUIT IN STORE FOR THE GROUP. 
<< Previous
Bullboard Posts
Next >>